Tsutomu Nakagawa
Directeur/Membre du Conseil chez SUMITOMO PHARMA CO., LTD.
Postes actifs de Tsutomu Nakagawa
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SUMITOMO PHARMA CO., LTD. | Directeur/Membre du Conseil | 25/06/2024 | - |
| Corporate Officer/Principal | 01/04/2016 | - | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Directeur/Membre du Conseil | 01/07/2023 | - |
| Directeur Général | 01/04/2024 | - | |
| President | 01/04/2024 | - | |
| Corporate Officer/Principal | 01/07/2023 | 01/04/2024 |
Historique de carrière de Tsutomu Nakagawa
Statistiques
Internationale
| Etats-Unis | 2 |
| Japon | 2 |
Opérationnelle
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SUMITOMO PHARMA CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
- Bourse
- Insiders
- Tsutomu Nakagawa
- Expérience
